Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M615Revenue $M7.0Net Margin (%)-593.5Altman Z-Score-4.6
Enterprise Value $M548EPS $-0.7Operating Margin %-504.6Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-593.5Higher ROA y-yY
Price/Book13.210-y EBITDA Growth Rate %-28.1Quick Ratio4.1Cash flow > EarningsY
Price/Sales53.85-y EBITDA Growth Rate %-16.1Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-62.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-126.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.5ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with AGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGENGeorge Soros 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 8.61193%Sold Out0
AGENFirst Eagle Investment 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 8.61193%Sold Out0
AGENGeorge Soros 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 8.61145%New holding102,200
AGENFirst Eagle Investment 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 8.61145%New holding200,000
AGENRobert Bruce 2012-06-30 Buy 0.52%$4.84 - $6.9
($5.78)
$ 8.6149%New holding233,515
AGENRobert Bruce 2010-12-31 Buy $5.34 - $6.48
($5.71)
$ 8.6151%New holding233,517
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGEN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Malik ShahzadDirector 2015-04-29Sell1,107,377$7.1121.1view
QVT Associates GP LLC10% Owner 2015-01-09Sell2,343,630$5.3162.15view
Wentworth KerryVP, Clinical, Reg & Qual 2014-02-26Sell5,000$572.2view
Malik ShahzadDirector 2014-02-12Sell0$072.2view
QVT Associates GP LLC10% Owner 2014-02-05Sell0$072.2view
Valentine KarenVP General Counsel 2014-01-23Sell2,850$3.5146view
Baysal OzerChief Business Officer 2013-06-13Sell0$0146view
Sharp ShaliniDirector 2013-01-30Sell288$4.3697.48view
Sharp ShaliniDirector 2012-10-31Sell288$4.495.68view
Sharp ShaliniDirector 2012-08-29Sell288$4.6485.56view

Quarterly/Annual Reports about AGEN:

News about AGEN:

Articles On GuruFocus.com
rusty Jan 26 2015 
Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine Jul 25 2014 
Agenus: Grossly Undervalued GlaxoSmithKline Acquisition Target Sep 10 2012 
5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
Weekly CEO Buys Highlight: CTAS, VRX, TAT, AGEN, MRK Aug 20 2011 
Chairman & CEO of Agenus Inc. (AGEN) Garo Armen Buys 2,150,976 Shares Aug 18 2011 
Antigenics Inc. Reports Operating Results (10-K) Mar 16 2011 
Antigenics Inc. Reports Operating Results (10-Q) Nov 09 2010 
Antigenics Inc. (AGEN) CFO Shalini Sharp sells 1,500 Shares Oct 28 2010 
Antigenics Inc. (AGEN) CFO Shalini Sharp sells 2,000 Shares Sep 14 2010 

More From Other Websites
AGENUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a... Jun 30 2015
Agenus Gets Billion-Dollar Valuation From Analyst Based on Cancer Drug That Doesn't Exist Jun 23 2015
Agenus to Webcast Annual Meeting of Stockholders Jun 22 2015
Agenus to Present at the 2015 JMP Securities Life Sciences Conference Jun 18 2015
AGENUS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial... Jun 17 2015
Agenus Appoints C. Evan Ballantyne as Chief Financial Officer Jun 17 2015
Agenus (AGEN) Stock Higher Following Coverage Initiation Jun 11 2015
Coverage initiated on Agenus by Oppenheimer Jun 11 2015
Agenus Gains after Merck Extends Immuno-Oncology Ties - Analyst Blog Jun 04 2015
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 03 2015
Merck Extends Immuno-Oncology Collaboration with Agenus Jun 03 2015
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 01 2015
Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median... Jun 01 2015
Agenus to Present at the Jefferies 2015 Healthcare Conference May 28 2015
AGENUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... May 27 2015
Agenus Announces Closing of Public Offering and Exercise in Full of Underwriters’ Option to... May 27 2015
4 stocks to watch May 27 2015
Agenus Announces Pricing of Its Public Offering of Common Stock May 21 2015
AGENUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 21 2015
Agenus Announces Proposed Public Offering of Common Stock May 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK